Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
Simcere Pharmaceutical Gr (OTC : SMHGF) Stock
MWN-AI** Summary
MWN-AI** Analysis
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Description
Simcere Pharmaceutical Group Ltd is engaged in the R&D, production and commercialization of pharmaceuticals focused on generic pharmaceuticals. It has a diversified product portfolio focused on therapeutic areas, including, oncology (including cell therapy), central nervous system diseases and autoimmune diseases. The company's products include Endostar, Enweida, Iremod, Softan and Sanbexin.
Quote
| Last: | $1.4895 |
|---|---|
| Change Percent: | 0.01% |
| Open: | $1.4894 |
| Close: | $1.4894 |
| High: | $1.4895 |
| Low: | $1.4895 |
| Volume: | 100 |
| Last Trade Date Time: | 03/09/2026 09:30:04 am |
Stock Data
| Market Cap: | $5,115,132,771 |
|---|---|
| Float: | 2,609,761,618 |
| Insiders Ownership: | N/A |
| Institutions: | |
| Short Percent: | N/A |
| Industry: | Pharmaceuticals |
| Sector: | Healthcare |
| Country: | CN |
| City: |
**MWN-AI FAQ is based on asking OpenAI questions about Simcere Pharmaceutical Gr (OTC: SMHGF).
